Navigation Links
Quanterix Corporation Announces the Addition of Dr. Robert Corn to its Scientific Advisory Board

Leader in single molecule detection to expand prominent Scientific Advisory


CAMBRIDGE, Mass., Nov. 11 /PRNewswire/ -- Quanterix Corporation, the leader in single molecule detection, announced today that Robert Corn, Ph.D. has joined its Scientific Advisory Board (SAB). Dr. Corn is a Professor in the Departments of Chemistry and Biomedical Engineering at the University of California, Irvine. Dr. Corn's primary research areas include the development of new methods for detecting binding of biomolecules to surfaces and chemical modification strategies to control specific and non-specific adsorption of biopolymers to a variety of surfaces.

Dr. David Walt, Scientific Founder of Quanterix and Chair of the SAB, stated, "Dr. Corn is a leader in the field of surface chemistry; his research interests and experience are directly applicable to our Single Molecule Array (SiMoA(TM)) technology. We are eager to draw upon his extensive knowledge and insight as we develop assays and instrumentation that enable unparalleled increases in analytical sensitivity for the detection of proteins implicated in a variety of diseases."

Dr. Corn added, "The novel technology platform being developed by Quanterix will provide medical researchers with a unique tool that allows low abundance biomarkers to be detected in complex biological samples. I am excited to join such a world class Advisory Board and look forward to working with the other members to further advance this promising technology."

Dr. Corn joins SAB members David Walt, Ph.D., Robinson Professor of Chemistry and Howard Hughes Medical Institute Professor, Tufts University (Chairman of the SAB), Larry J. Kricka, D. Phil., Professor of Pathology and Laboratory Medicine at the University of Pennsylvania and Director of the General Chemistry Laboratory at the Hospital of the University of Pennsylvania, J. Michael Ramsey, Ph.D., Minnie N. Goldby Distinguished Professor of Chemistry and Chair at the University of North Carolina at Chapel Hill, and Sunney Xie, Ph.D., Professor of Chemistry at Harvard University.

About Quanterix

Quanterix is developing a revolutionary Single Molecule Array (SiMoA(TM)) technology that allows the behavior of thousands of individual molecules to be observed simultaneously, rather than an ensemble average of many molecules as with existing technologies. Quanterix's platform will bring an unprecedented level of sensitivity, precision, and assay robustness to clinical diagnostics, drug development, and life science research. The first application that Quanterix is pursuing with the SiMoA(TM) technology is the detection and quantification of proteins present in blood and other body fluids at very low, previously undetectable, concentrations. Diagnostic assays targeting proteins that have been implicated in a variety of human diseases, including cancer, chronic inflammatory disease and cardiovascular disease are under development. Quanterix is a privately held company located in Cambridge, Massachusetts and is backed by leading life science investors including ARCH Venture Partners, Bain Capital Ventures, and Flagship Ventures. For additional information, please visit

SOURCE Quanterix Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Azur Pharma and Elan Corporation (NYSE: ELN) Sign Agreement to Develop a Once-Daily Clozapine
2. Medical Simulation Corporation Announces Partnership With University of South Florida
3. Environmental Power Corporation and Organix, Inc. Establish Alliance to Produce High Value Soil Amendment Products
4. Environmental Tectonics Corporation Announces Staff Addition to Its BioMedical Systems Division
5. Verenium Corporation to Speak at the Credit Suisse Alternative Energy Conference
6. Health Robotics Announces Contract for its CytoCare(TM) and IV Station(TM) Robots With Arabian Health Care Supply Corporation
7. DURECT Corporation Announces Third Quarter 2008 Financial Results
8. Verenium Corporation to Announce Third Quarter 2008 Financial Results
9. Environmental Tectonics Corporations Simulation Division Receives New ADMS Contract from Netherlands Institute for Safety
10. AMERIGROUP Corporation Named One of Best Places to Work in Healthcare
11. STERIS Corporation Announces Fiscal 2009 Second Quarter and First Half Results
Post Your Comments:
(Date:11/24/2015)... 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... New York on Wednesday, December 2 at 9:30 ... president and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim ... provide a corporate overview. --> th Annual Oppenheimer ...
(Date:11/24/2015)... ... November 24, 2015 , ... Copper ... unless it is bound to proteins, copper is also toxic to cells. With ... Worcester Polytechnic Institute (WPI) will conduct a systematic study of copper in the ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... IIROC on behalf of the Toronto Stock Exchange, confirms ... there are no corporate developments that would cause the ... --> --> About Aeterna Zentaris ... . --> Aeterna Zentaris is a specialty ...
(Date:11/24/2015)... November 24, 2015 --> ... research report "Oligonucleotide Synthesis Market by Product & Services ... Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, ... MarketsandMarkets, the market is expected to reach USD 1,918.6 ... at a CAGR of 10.1% during the forecast period. ...
Breaking Biology Technology:
(Date:11/17/2015)... PARIS , November 17, 2015 ... November 2015.   --> Paris from ... --> DERMALOG, the biometrics innovation leader, has invented the ... and fingerprints on the same scanning surface. Until now two ... fingerprints. Now one scanner can capture both on the same ...
(Date:11/12/2015)... -- A golden retriever that stayed healthy despite having the ... a new lead for treating this muscle-wasting disorder, report ... MIT and Harvard and the University of São Paolo ... Cell, pinpoints a protective gene that boosts muscle ... Boston Children,s lab of Lou Kunkel , PhD, ...
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
Breaking Biology News(10 mins):